17.Limitations
1.No Neonatal use
Do not use for neonatal blood glucose testing
.
2.Hematocrit range
Hematocrit in the range of 32~60% has been shown not to affect the
glucose results. If you do not know your hematocrit level, consult
your healthcare professional.
3.Hemoglobin range
Hemoglobin levels of 0.078 mmol/L did not interfere with blood
glucose test results.
4.Elevated Cholesterol and Triglycerides
Cholesterol levels up to 12.9 mmol/L and Triglycerides up to 33.1
mmol/L has been shown not to affect glucose results.
5.Medications
Interference was observed for therapeutic levels of L-DOPA.
No interference was shown for uric acid, acetaminophen, ascorbic
acid and ibuprofen in normal therapeutic levels. However, higher
concentrations in blood may cause incorrect results:
Uric acid: > 0.65 mmol/L; acetaminophen: >0.41mmol/L ;
ascorbic acid: >0.26 mmol/L; ibuprofen: >1.82 mmol/L.
6.The test strips may be used at altitudes up to 5,280 feet (1,609 m )
without an effect on test results.
7.Persons suffering from severe dehydration should not be tested
using a capillary whole blood sample.
8.Test results below 3.9 mmol/L indicate low blood glucose
(hypoglycemia). Test results greater than 13.3 mmol/L indicate
high blood glucose (hyperglycemia). If you get results below 3.9
mmol/L or above 13.3 mmol/L, repeat the test, and if the results
are still below 3.9 mmol/L or above 13.3 mmol/L , please consult
2
your healthcare professional immediately
.
9.Inaccurate results may occur for individuals experiencing a
hyperglycemic-hyperosmolar state, with or without ketosis.
Critically ill patients should not be tested with a blood glucose
meter.
29
